Scoring System Based on RNA Modification Writer-Related Genes to Predict Overall Survival and Therapeutic Response in Bladder Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Scoring System Based on RNA Modification Writer-Related Genes to Predict Overall Survival and Therapeutic Response in Bladder Cancer
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-08-31
DOI
10.3389/fimmu.2021.724541
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer
- (2021) Huifang Chen et al. Molecular Cancer
- Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis
- (2021) Ganping Wang et al. Frontiers in Cell and Developmental Biology
- A new m6A methylation-related gene signature for prognostic value in patient with urothelial carcinoma of the bladder
- (2021) Bin Zheng et al. BIOSCIENCE REPORTS
- Identification of an Immune-Related Risk Signature Correlates With Immunophenotype and Predicts Anti-PD-L1 Efficacy of Urothelial Cancer
- (2021) Pengju Li et al. Frontiers in Cell and Developmental Biology
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes
- (2020) Huaide Qiu et al. Frontiers in Genetics
- Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer
- (2020) Yuxuan Song et al. Aging-US
- FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†
- (2020) Bas W.G. van Rhijn et al. EUROPEAN UROLOGY
- Microenvironment-related gene TNFSF13B predicts poor prognosis in kidney renal clear cell carcinoma
- (2020) Mingzhe Jiang et al. PeerJ
- Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer
- (2020) Yongwen Luo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis
- (2020) Yuying Han et al. World Journal of Surgical Oncology
- METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner
- (2019) Jie Han et al. Molecular Cancer
- An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer
- (2019) Penghu Lian et al. Aging-US
- An EMT‐related gene signature for the prognosis of human bladder cancer
- (2019) Rui Cao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Biomarkers for neoadjuvant checkpoint blockade response in urothelial cancer
- (2019) Pooja Ghatalia et al. NATURE MEDICINE
- Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kγ to promote pancreatic cancer metastasis
- (2018) Xiaofeng Wang et al. CANCER RESEARCH
- Neurotensin/IL-8 pathway orchestrates local inflammatory response and tumor invasion by inducing M2 polarization of Tumor-Associated macrophages and epithelial-mesenchymal transition of hepatocellular carcinoma cells
- (2018) Pei Xiao et al. OncoImmunology
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- m6A modulates haematopoietic stem and progenitor cell specification
- (2017) Chunxia Zhang et al. NATURE
- Genomic Approaches to Understanding Response and Resistance to Immunotherapy
- (2016) D. A. Braun et al. CLINICAL CANCER RESEARCH
- Microsatellite Instability as a Biomarker for PD-1 Blockade
- (2016) J. C. Dudley et al. CLINICAL CANCER RESEARCH
- Pathology and Genetics: Tumours of the Urinary System and Male Genital System
- (2016) Rodolfo Montironi et al. EUROPEAN UROLOGY
- A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer
- (2016) David J. McConkey et al. EUROPEAN UROLOGY
- A new methyl mark on messengers
- (2016) Anna M. Kietrys et al. NATURE
- The dynamic N1-methyladenosine methylome in eukaryotic messenger RNA
- (2016) Dan Dominissini et al. NATURE
- mRNA capping: biological functions and applications
- (2016) Anand Ramanathan et al. NUCLEIC ACIDS RESEARCH
- The use of vector bootstrapping to improve variable selection precision in Lasso models
- (2016) Charles Laurin et al. Statistical Applications in Genetics and Molecular Biology
- The use of vector bootstrapping to improve variable selection precision in Lasso models
- (2016) Charles Laurin et al. Statistical Applications in Genetics and Molecular Biology
- Bladder Cancer and Genetic Mutations
- (2015) Xiaoying Zhang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
- (2015) Antonio Colaprico et al. NUCLEIC ACIDS RESEARCH
- The Many Alternative Faces of Macrophage Activation
- (2015) David A. Hume Frontiers in Immunology
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Alternative polyadenylation is associated with lower expression of PABPN1 and poor prognosis in non-small cell lung cancer
- (2014) Junji Ichinose et al. CANCER SCIENCE
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis
- (2014) Xiaodan Ji et al. eLife
- Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines
- (2014) Paul Geeleher et al. GENOME BIOLOGY
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- Alternative cleavage and polyadenylation: extent, regulation and function
- (2013) Ran Elkon et al. NATURE REVIEWS GENETICS
- Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder Cancer
- (2012) Markus Riester et al. CLINICAL CANCER RESEARCH
- A Molecular Taxonomy for Urothelial Carcinoma
- (2012) G. Sjodahl et al. CLINICAL CANCER RESEARCH
- LARP7 is a potential tumor suppressor gene in gastric cancer
- (2012) Yulan Cheng et al. LABORATORY INVESTIGATION
- Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma
- (2012) David Lindgren et al. PLoS One
- RNA nucleotide methylation
- (2011) Yuri Motorin et al. Wiley Interdisciplinary Reviews-RNA
- Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors
- (2010) Ju-Seog Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Epithelial-Mesenchymal Transitions in development and disease: old views and new perspectives
- (2009) M. Angela Nieto INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started